Informație de încredere. Sprijin real.

NeuroPsy InfoHub adună studii și articole verificate editorial despre sănătate mintală și afecțiuni neurologice — pentru pacienți, familii și specialiști.

Spațiu publicitar disponibil — bannerul mare de susSpațiu publicitar disponibil — bannerul mare de sus

Explorează temele

Caută tot →

Sănătate mintală și neurodezvoltare

Afecțiuni neurologice

Articole și ghiduri recomandate

StudiuEpilepsieÎncredere bună22.06.2026

Dostoevsky's Epilepsy and its Portrayal in The Brothers Karamazov

Fyodor Dostoevsky, a 19th-century Russian novelist with epilepsy, incorporated his personal experience with seizure disorder into his novels, particularly in The Brothers Karamazov where he explores family dynamics and uses psychogenic non-epileptic seizures as a narrative element in the character Smerdyakov's criminal alibi.

PresăEpilepsieÎncredere bună19.06.2026

Study assesses seizure risk from stimulating thalamus

Researchers demonstrated in awake mice that low-current deep brain stimulation of the central thalamus can occasionally trigger electrographic seizures. This finding highlights important safety considerations for thalamic stimulation as a therapeutic approach.

PresăEpilepsieÎncredere înaltă19.06.2026

Vital Language Sites in Brain Act Like Connectors in a Social Network

Researchers have identified key language-processing areas in the cerebral cortex that function as interconnected hubs, similar to social networks, which could help surgeons better preserve language function during brain tumor or epilepsy surgery. This study advances understanding of how language is encoded in the brain and provides insights to guide surgical decision-making for improved post-operative language outcomes.

PresăEpilepsieÎncredere bună19.06.2026

New drug cuts seizures by up to 91% in children with rare epilepsy

An experimental drug called zorevunersen shows significant promise for children with Dravet syndrome by reducing seizures up to 91% and improving quality of life through enhanced gene function in nerve cell signaling. Positive trial results have prompted researchers to advance to larger Phase 3 clinical trials.